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ReviewThe LDL Receptor Gene Family:
(Un)Expected Signal Transducers in the Brain
LDL Receptor
The best-studied member of the family is the LDL recep-
tor (Goldstein et al., 2001). Its role in the regulation of
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plasma cholesterol levels and the removal of LDL from5323 Harry Hines Boulevard
the circulation is generally well known. Humans andDallas, Texas 75390
rabbits that are homozygous for naturally occurring re-
ceptor-inactivating mutations and mice in which the LDL
Introduction receptor gene has been destroyed by gene targeting
The core members of the low-density lipoprotein (LDL) (Ishibashi et al., 1993) all manifest grossly elevated
receptor gene family currently consist of seven structur- plasma cholesterol levels that cause severe atheroscle-
ally closely related cell surface receptors (Willnow et al., rosis. Endocytosis via clathrin-coated pits is essential
1999; Herz and Beffert, 2000). For historical reasons, for cellular uptake of LDL by this receptor. Mutations in
the biological function that was initially attributed to all the cytoplasmic tail that affect the ability of the receptor
members of this evolutionarily ancient gene family is a to interact with the endocytosis machinery prevent the
role in lipid metabolism. The LDL receptor was the first cellular uptake of the LDL particle bound to the extracel-
member of the family to be identified, and its prominent lular ligand binding domain. An NPxY (Asn, Pro, any
role in the homeostasis of cholesterol and the removal amino acid, Tyr) tetra–amino acid sequence motif is
of LDL from the circulation has been studied extensively. highly conserved in the cytoplasmic tails of numerous
The process of receptor-mediated endocytosis was in cell surface receptors and is critical for the clustering
large part worked out by studying the LDL receptor and of the LDL receptor into coated pits (Davis et al., 1987;
the cellular uptake of LDL (Brown and Goldstein, 1986). Chen et al., 1990). Despite extensive studies on the cell
However, over the last 10 years, the other members of biology, genetics, and physiology—over 600 naturally
the family have been found to engage in a number of occurring functional mutations in the LDL receptor gene
have been identified to date in humans—no functionsother biological functions (Table 1), including the regula-
other than LDL removal and the regulation of cholesteroltion of cell surface protease activity, the transport and
homeostasis have been shown conclusively for this re-activation of steroid hormones, the regulation of Ca21
ceptor (Goldstein et al., 2001).homeostasis, and pivotal roles in intercellular signaling
LRPduring embryonic development. Even roles in NMDA
In the liver, the LDL receptor cooperates with the LDLreceptor-mediated neurotransmission and long-term
receptor-related protein (LRP) in the removal of choles-potentiation have been reported recently. Here, I review
terol-containing “remnant” lipoproteins from the circula-these diverse biological roles of this multifunctional
tion (Willnow et al., 1995, 1994; Rohlmann et al., 1998).gene family.
LRP is one of the largest known cell surface proteins
(z600 kDa). It was discovered as the second member
Genetics of the LDL Receptor Gene Family of the LDL receptor gene family during a screen of cDNA
The core members of the LDL receptor gene family (Fig- libraries for proteins that contain the type of cysteine-
ure 1A) include the LDL receptor (Yamamoto et al., rich amino acid repeats present in the ligand binding
domain in the LDL receptor (Herz et al., 1988). LRP is1984), the LDL receptor-related protein (LRP) (Herz et
expressed on the blood sinusoidal surface of hepato-al., 1988), megalin (Saito et al., 1994), VLDL receptor
cytes in the liver, and like the LDL receptor, LRP binds(Takahashi et al., 1992), ApoE receptor-2 (ApoER2) (Kim
ApoE-containing lipoproteins in vitro and mediates theiret al., 1996; Novak et al., 1996), LRP1b (a.k.a. LRP-DIT)
endocytosis in cultured cells. LRP does not bind LDL(Liu et al., 2000), and MEGF7 (Nakayama et al., 1998).
and thus is incapable of compensating for the lack ofApolipoprotein E (ApoE), the product of a gene that has
LDL receptor function in LDL receptor–deficient individ-been implicated in late-onset Alzheimer disease (AD)
uals (reviewed in Krieger and Herz, 1994). The role of(Schmechel et al., 1993), binds to most, if not to all, of
the LRP in lipoprotein metabolism is therefore muchthese receptors.
more restricted than that of the LDL receptor, which canSeveral more distantly related genes encoding cell
fully compensate for the lack of functional LRP in thesurface proteins that share some but not all of the struc-
liver (Rohlmann et al., 1998).tural elements that distinguish the core members of the
LRP is a multifunctional receptor that interacts withfamily have been recognized more recently and include
a broad range of secreted proteins, as well as with resi-LR11 (SORLA) (Jacobsen et al., 1996; Morwald et al.,
dent cell surface molecules. Soluble ligands for LRP1997), LRP5 (Dong et al., 1998; Hey et al., 1998), and
include proteases and protease inhibitor complexes,LRP6 (Brown et al., 1998) (Figure 1B). These proteins
such as plasminogen activators, plasminogen activatorcontain several copies of the same type of ligand binding
inhibitor-1, a2-macroglobulin, etc. (Krieger and Herz,repeats that are known to mediate the interaction of the
1994). This multifunctionality is likely the reason for theLDL receptor with ApoE and with ApoB, the sole protein
early embryonic lethality of mouse embryos in which thein LDL (Esser et al., 1988).
LRP gene has been disrupted in all cells by conventional
gene targeting (Herz et al., 1992, 1993). Although most
of these embryos die during the periimplantation period,* E-mail: herz@utsw.swmed.edu
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Table 1. Properties of LDD Receptor Family Members
Receptor Ligands Functions Mutational Phenotypes
LDL receptor ApoB, ApoE Lipoprotein/cholesterol uptake Familial hypercholesterolemia,
atherosclerosis, heart disease
LRP ApoE, a2-macroglobulin, plasminogen Lipoprotein and protease uptake, Conventional knockout is early
activators, protease/inhibitor complexes, synaptic transmission, modulation of embryonic lethal; liver-specific
lipase, APP APP processing? knockout viable, lipoprotein
clearance defect
Megalin ApoB, ApoE, proteases and inhibitors, carrier Embryonic cholesterol homeostasis ?, Holoprosencephaly, vitamin D
proteins for lipophilic vitamins, Ca21-homeostasis, required deficiency
parathyroid hormone for forebrain development
VLDL receptor ApoE, Reelin Cortical lamination, neuronal Rostral cerebellar foliation
migration, predomininant Reelin defects
receptor in the cerebellum
ApoER2 ApoE, Reelin Cortical lamination, neuronal Severe cortical and hippocampal
migration, predominant Reelin lamination defects, vldlr/
receptor in the neocortex apoer2 double mutants are
phenotypically indistinguish-
able from reeler mice
LRP1b Unknown, ApoE binding likely Frequently deleted in tumors, role in Unknown
tissue remodeling and metastasis?
MEGF7 Unknown, ApoE binding likely Expression in the brain suggests Unknown
possible roles during development
and maintenance of the CNS
LRP6 Wnts, ApoE? Forms complex with Wnts, Frizzled, Combines spectrum of individual
and proteoglycans, required for wnt mutant phenotypes
Wnt signaling
LRP5 Likely similar functions as LRP6 — —
LR11/SorLA Head activator (HA), ApoE Cell proliferation, head regeneration Unknown
in hydra, distinct expression during
brain development, upregulated in
atherosclerotic lesions
a few have been found to survive to approximately E10. reduced supply of cholesterol to this region in the em-
bryo (Farese and Herz, 1998).These surviving embryos displayed various abnormali-
ties, including defects in the formation of cephalic vesi- Indeed, the localization of megalin on the apical sur-
face of villous epithelia suggests a resorptive function.cles (Herz et al., 1993). LRP also directly and indirectly
interacts with the amyloid precursor protein (APP) Like the closely related LRP, megalin is a multifunctional
receptor that shares some but not all of the ligand bind-(Kounnas et al., 1995; Trommsdorff et al., 1998), but the
biological relevance of this interaction remains to be ing properties of LRP (Krieger and Herz, 1994). Notably,
megalin can bind several classes of cholesterol-rich li-determined.
Megalin poproteins. Mice that lack apolipoprotein B, a structural
component of the major cholesterol-carrying lipopro-The overall structural organization of megalin is very
similar to that of LRP, and the two proteins are of similar teins, including LDL and remnant lipoproteins that bind
to megalin, die during early midgestation and exhibitsize. However, the expression pattern of megalin is quite
different from that of LRP. Megalin is primarily ex- severe neuroectodermal atrophy (Farese et al., 1996).
Similarly, the yolk sac of mouse embryos that lack micro-pressed on the apical surface of polarized epithelia,
such as the proximal tubule in the kidney, alveolar cells somal triglyceride transfer protein (MTP) is unable to
secrete lipoproteins, resulting in essentially the identicalin the lung, epithelial cells in the intestine, and the epen-
dymal cells that line the ventricles in the brain. Early phenotype as ApoB deficiency (Raabe et al., 1998). In
megalin-deficient mouse embryos, the rostral parts ofduring development megalin is expressed by the troph-
ectoderm, the yolk sac, and on the apical surface of the the neuroepithelium, which give rise to the rapidly ex-
panding forebrain, may be preferentially starved for cho-neuroepithelium (Willnow et al., 1996).
A prominent feature of knockout mice deficient for lesterol to the point that endogenous synthesis and
compensatory uptake by other receptors is unable tomegalin is a developmental defect of the forebrain
known as holoprosencephaly. Holoprosencephalic syn- keep up with the demand imposed by the rapid rate of
cell division. Consistent with such a model is the findingdromes in man are frequently caused by defects in the
terminal steps of the cholesterol biosynthetic pathway that the telencephalic vesicles are significantly smaller
in megalin knockout embryos. This phenotype is already(Tint et al., 1994; Fitzky et al., 1998). Mutations in the
sonic hedgehog (shh) gene also cause holoprosenceph- evident on embryonic day 8 of development (Willnow et
al., 1996). Although suggestive, the available data doaly in humans (Roessler et al., 1996) and mice (Chiang
et al., 1996). Processing of the Shh protein precursor to not conclusively prove that a defect in cholesterol import
is the sole basis for this phenotype. Alternatively, mega-its active form requires cholesterol (Muenke and
Beachy, 2000), raising the possibility that the forebrain lin may fulfill hitherto unrecognized signaling functions
that have predominant impact on cell division and differ-defect in megalin-deficient mice might be caused by a
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Figure 1. The LDL Receptor Gene Family
(A) The core of the LDL receptor gene family consists of the LDL receptor (LDLR), VLDL receptor (VLDLR), Apolipoprotein E receptor-2
(ApoER2), multiple epidermal growth factor containing protein 7 (MEGF7), LDL receptor-related protein (LRP), LRP1b, and megalin. All receptors
are anchored in the plasma membrane by a single membrane–spanning segment and contain a short cytoplasmic tail between 50 and z200
amino acids. Between one and three NPxY motifs are present. This motif mediates the interaction of the receptors with the endocytosis
machinery, as well as with an expanding range of cytoplasmic adaptor and scaffold proteins (Gotthardt et al., 2000). These include Dab1,
JIP1 and JIP2, semaphorin cytoplasmic tail–associated proteins (SEMCAPs), and FE65 (Trommsdorff et al., 1998). The extracellular domains
consist of arrays of ligand binding–type repeats (red ovals), always followed by epidermal growth factor (EGF) homology domains (yellow).
The number of ligand binding–type repeats in the ApoER2 gene varies between seven and eight.
(B) Distantly related receptors. These include the Wnt receptor LRP6, the closely related LRP5, and LR11/SorLA, a receptor for head activator,
a neuropeptide. Their domain structure is different from that of the core members of the family. LRP5 and LRP 6 do not contain NPxY motifs
in their cytoplasmic tails. LR11/SorLA harbors a VPS10 homology domain and six fibronectin repeats (blue ovals).
entiation in the region of the developing forebrain. Possi- ing through a specific seven-transmembrane receptor
(Hilpert et al., 1999). Alterations in the expression ofble mechanisms by which megalin might participate in
cellular signaling during this early phase of brain devel- megalin thus modulate PTH signaling and thereby cal-
cium excretion. In both cases, however, by mediatingopment have emerged from the analysis of VLDL recep-
tor and ApoER2 knockout mice (see below). the endocytic uptake of DBP or of PTH, megalin does
not transmit a signal of its own in the classic sense, i.e.,Recently, megalin was found to participate in the regu-
lation of cellular signaling involving certain steroid hor- one elicited by direct binding of a ligand to a cell surface
receptor.mones, specifically vitamin D, a key regulator of calcium
homeostasis. Vitamin D binding protein (DBP) was iden- VLDL Receptor and ApoER2
The primary structure and size of the VLDL receptortified in the urine of the small number of megalin-defi-
cient mice that escaped perinatal death and survived and the ApoER2 is almost identical to that of the LDL
receptor. Both, VLDL receptor and ApoER2 were identi-to adulthood. DBP serves as a carrier for monohydroxy-
lated 25(OH)-vitamin D3. Megalin was shown to mediate fied in the course of genome-wide searches for LDL
receptor–related genes (Takahashi et al., 1992; Kim etthe uptake of this provitamin/DBP complex from the
primary glomerular filtrate into the cells lining the proxi- al., 1996; Novak et al., 1996). Due to their striking similar-
ity to the LDL receptor and because they both bindmal tubules of the kidney. In the proximal tubules, enzy-
matic conversion takes place to the fully active dihy- ApoE in vitro, functions in lipoprotein metabolism were
initially proposed for both receptors and are reflecteddroxylated 1,25(OH)2 form of vitamin D3. Because this
pathway is interrupted in megalin-deficient mice, these in the names assigned to them. However, neither recep-
tor is expressed in the liver, the main organ for theanimals are severely deficient in vitamin D and exhibit
typical defects in bone calcification (Nykjaer et al., 1999). metabolism of lipoproteins in vivo. The primary sites of
expression of the VLDL receptor are the endotheliumMegalin is also involved at yet another level of sys-
temic calcium homeostasis. In the parathyroid gland and muscle (Jokinen et al., 1994; Wyne et al., 1996).
The expression pattern of the ApoER2 is even moreand in the kidney, megalin is produced by the same
cells that express the receptor for parathyroid hormone restricted. It is expressed virtually exclusively in neural
tissues and in the testes of adult mice (Stockinger et(PTH). Megalin binds to and internalizes with PTH,
thereby making PTH unavailable for binding and signal- al., 1998, 2000). An initial phenotypic analysis of VLDL
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receptor knockout mice did not reveal any detectable (Pinson et al., 2000) has recently identified LRP6 as
alteration in systemic lipoprotein metabolism (Frykman an obligate coreceptor in the Wnt signaling pathway.
et al., 1995), suggesting that this gene may have func- Because of its high homology to LRP6, LRP5 is likely
tions that are unrelated to lipid metabolism. to function in an analogous manner.
A pivotal role in neural development of the VLDL re- LR11 (SORLA)
ceptor and ApoER2 was revealed when knockout mice This protein is another member of the gene family that
lacking either the VLDL receptor or the ApoER2 were shares several of the structural features with the core
crossed to generate vldlr/apoer2 double-mutant ani- members of the family but contains additional structural
mals (Trommsdorff et al., 1999). The doubly deficient and functional domains found in unrelated proteins (Ja-
mice developed profound ataxia starting around 2 cobsen et al., 1996; Yamazaki et al., 1996; Morwald et
weeks after birth, caused by severe cerebellar dysplasia. al., 1997). In addition to an EGF precursor homology
Histological examination revealed defects in neuronal domain and a cluster of 11 ligand binding–type repeats,
positioning affecting primarily the hippocampus, the LR11 also harbors a VPS10 homology domain and 6
lamination of the neocortex, and the cerebellum. This fibronectin type III repeats. LR11 is anchored in the
phenotype was indistinguishable from that reported for plasma membrane by a single membrane spanning seg-
two naturally occurring mutant strains of mice, reeler ment and contains an NPxY motif in its cytoplasmic tail.
(Falconer, 1951) and scrambler (Sweet et al., 1996). In Two ligands are known that bind to the extracellular
the reeler mouse, functional expression of the large domain of LR11/SORLA. One is ApoE, which presum-
modular protein Reelin is lacking. Reelin is thought to ably binds to the cluster of ligand binding–type repeats,
regulate cortical lamination by providing positional cues and the other is head activator (HA). This short neuro-
to migrating neurons (D’Arcangelo et al., 1995). In con- peptide and its receptor LR11 have been remarkably
trast, in the scrambler mouse the cytoplasmic adaptor conserved throughout evolution. Both are found in hy-
protein Disabled-1 (Dab1) is defective (Howell et al., dra, a primitive marine organism where HA and LR11/
1997; Sheldon et al., 1997; Ware et al., 1997). Both Reelin SORLA participate in head regeneration (Hampe et al.,
and Dab1 function in a linear pathway (Howell et al., 1999a, 1999b). LR11/SORLA participates in the trans-
1999). However, the receptor(s) to which Reelin binds mission of the signal elicited by HA. The precise mecha-
and that transmits the signal to the cytoplasm of migrat- nisms have not yet been delineated but may involve
ing neurons was not known. coupling to Gi, Ca21, and K1 channels (Hampe et al.,
The phenotypic similarity between reeler, scrambler, 2000). In mammals, HA is produced primarily in the hy-
and vldlr/apoer2 mutants suggested that the VLDL re- pothalamus, and LR11/SORLA is involved in the prolifer-
ceptor and ApoER2 might be these elusive Reelin recep- ation of several types of neuronal cell lines induced by
tors. This hypothesis is supported by biochemical evi- HA (Hampe et al., 2000; Hirayama et al., 2000). LR11/
dence that showed binding of Reelin to the extracellular SORLA is also markedly upregulated during the forma-
domains of the VLDL receptor and the ApoER2 (D’Ar- tion of atherosclerotic lesions in the vascular wall, a
cangelo et al., 1999; Hiesberger et al., 1999), but not process that involves the migration and proliferation of
(Hiesberger et al., 1999) or with greatly reduced affinity vascular smooth muscle cells (Kanaki et al., 1999).
(D’Arcangelo et al., 1999) to the closely related LDL Whether HA is involved in this process is unclear, but
receptor. Furthermore, Dab1, a PTB domain-containing it is possible that ApoE, which plays a major role during
protein, interacts with NPxY motifs in the cytoplasmic the development of atherosclerotic lesions, interacts
tails of both receptors (Trommsdorff et al., 1999), and with LR11/SORLA and thereby modulates smooth mus-
binding of Reelin to their extracellular domains is required cle cell proliferation.
to induce tyrosine phosphorylation of Dab1 (D’Arcangelo Although HA and LR11/SORLA play important roles
et al., 1999; Hiesberger et al., 1999). These findings es- for head regeneration in hydra, their role for the develop-
tablished hitherto unrecognized signaling functions for
ment of the mammalian nervous system is unclear (Ka-
members of the LDL receptor family that went beyond
naki et al., 1998). The gene from which HA is derived
ligand endocytosis and involved the activation of intra-
has so far not been cloned, and no LR11/SORLA-defi-cellular kinases.
cient mice have been generated so far.LRP5 and 6
LRP1b and MEGF7Further support for a general role of the LDL receptor
The most recent additions to the LDL receptor genegene family in signal transduction, particularly during
family are LRP1b and MEGF7 (Figure 1A). Accordingly,development, has come from independent studies on
there is little information available about their biologicalthe role of LRP6. LRP5 and LRP6 are highly homologous
functions. LRP1b was originally identified as LRP-DITproteins that constitute a subfamily of LDL receptor–
(LRP-deleted in tumors) (Liu et al., 2000). Forty percentrelated genes (Figure 1B) (Brown et al., 1998; Dong et
of certain types of tumors were found to harbor inactivat-al., 1998; Hey et al., 1998). Their cytoplasmic tails do
ing mutations in this gene, suggesting that LRP1b maynot contain NPxY motifs, which mediate interactions
play crucial roles in growth regulation or migration ofwith PTB domain containing adaptor proteins such as
cells. The genomic structure of LRP1b is almost identicalDab1. Furthermore, although the extracellular domains
to that of LRP, with which LRP1b shares z60% aminoof LRP5 and LRP6 contain ligand binding–type repeats
acid identity.and EGF precursor homology domains, they are ar-
MEGF7 was identified during a motif trap screen ofranged differently than in the seven core members of
large transcripts containing EGF repeats that are ex-the LDL receptor gene family. Genetic and biochemical
pressed in the mammalian brain (Nakayama et al., 1998).evidence in three different species, Drosophila (Wehrli
et al., 2000), Xenopus (Tamai et al., 2000), and mouse An ortholog of MEGF7 exists in Drosophila (Adams et
Review
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al., 2000), but as in higher organisms, nothing is currently labon et al., 2000). The importance of integrins for normal
cortical lamination is well established (Georges-Labou-known about its function.
esse et al., 1998; Zhang and Galileo, 1998; Anton et al.,
1999). Mice in which the gene encoding the a3 subunitNeuronal Migration and Cortical Lamination
has been disrupted (Anton et al., 1999) show some ofConsiderable genetic and biochemical evidence indi-
the features that are characteristic for defects in thecates that the VLDL receptor and ApoER2 are part of a
Reelin signaling pathway, in particular disruptions of theneuronal signaling pathway that is important for brain
normal pattern of cortical lamination. In support of adevelopment (D’Arcangelo et al., 1999; Hiesberger et
possible role of integrins in Reelin signaling, a3b1 integrinal., 1999; Trommsdorff et al., 1999). Both VLDL receptor
has been found to bind to Reelin in a complex with VLDLand ApoER2 are receptors for Reelin, a large modular
receptor and ApoER2 (Dulabon et al., 2000). Further-protein that is secreted by certain types of neurons in-
more, Dab1 protein levels are significantly reduced, andcluding Cajal-Retzius neurons in the marginal zone of
a proteolytically processed 180 kDa form of Reelin isthe developing cortex and by the external granule layer
increased in a3-deficient mouse brains, providing indi-in the cerebellar anlage. The role of Reelin during cortical
rect support for an involvement of this integrin in Reelinlamination has been studied in detail and has been the
signaling. By contrast, Dab1 levels are greatly elevatedsubject of several excellent reviews (Lambert de Rou-
in reeler brains (Howell et al., 1999) and in the brains ofvroit and Goffinet, 1998; Rice and Curran, 1999). Reelin
mice lacking VLDL receptor and ApoER2 (Trommsdorffbinds to the extracellular domains of VLDL receptor and
et al., 1999). Integrins are also known to associate withApoER2 with subnanomolar affinity. This binding in-
tyrosine kinases (Schlaepfer and Hunter, 1998) and mayduces tyrosine phosphorylation of Dab1, which interacts
thus recruit the kinase that phosphorylates Dab1 to thewith NPxY motifs in the cytoplasmic tails of VLDL recep-
complex (Hiesberger et al., 1999; Howell et al., 1999).tor and ApoER2 and other members of the LDL receptor
Although a3b1 and possibly other integrins are excel-gene family (Trommsdorff et al., 1998, 1999). Tyrosine
lent candidates for Reelin coreceptors, the Reelin signal-phosphorylation of Dab1 is required for transmission of
ing complex is certain to contain more components,the Reelin signal to the migrating neurons. A mutant
both on the extracellular as on the intracellular face ofform of Dab1 in which tyrosine residues have been re-
the plasma membrane. For example, genetic evidenceplaced by phenylalanines (5F-Dab), and that therefore
shows that VLDL receptor and ApoER2 have distinctcannot be phosphorylated at these sites, is incapable
functions in the transmission of the Reelin signal, al-of transmitting the signal. Knockin mice that are homo-
though both bind this ligand with similar affinity (D’Ar-zygous for 5F-Dab are indistinguishable from reeler,
cangelo et al., 1999; Hiesberger et al., 1999). Lack ofscrambler, or Dab1 knockout mice, indicating that tyro-
VLDL receptor expression manifests itself primarily insine phosphorylation of Dab1 at these positions is cru-
the cerebellum, where the formation of a tight corticalcial to its function (Howell et al., 2000). The tyrosine
Purkinje cell layer is impaired, resulting in a mild andresidues that are substrates for Src and that are prefer-
mostly rostral foliation defect. In contrast, cerebellarentially phosphorylated by Reelin have recently been
development in ApoER2 knockout mice is minimally af-identified (Keshvara et al., 2001).
fected, but the lamination of the neocortex and the for-Taken together, these experiments have identified
mation of the hippocampus are severely disturbedfour consecutive steps in the Reelin signaling pathway:
(Trommsdorff et al., 1999). It is possible that the recep-(1) Reelin binds to (2) VLDL receptor and ApoER2, which
tors either bind additional ligands at their extracellularin turn bind (3) Dab1, and (4) leads to the addition of
domains that modulate the Reelin signal, that they inter-tyrosine phosphate residues to Dab1 in response to
act with distinct sets of intracellular proteins involvedReelin. Each one of these steps is crucial for the trans-
in the interpretation of the signal, or both. Indeed, differ-mission of the Reelin signal. However, these four gene
ences between the cytoplasmic tails of VLDL receptorproducts constitute only one branch of a more complex
and ApoER2 suggest specialized roles for either recep-signaling pathway. For one, the tyrosine kinase that in-
tor and indicate that Dab1 is not the only adaptor orduces the phosphorylation of Dab1 in response to the
scaffold protein that interacts with the receptor tails andReelin signal is still not known. This kinase may be a
that is involved in the signaling process. For instance,known or a yet unidentified receptor tyrosine kinase that
the ApoER2 tail harbors an alternatively spliced exoncan bind Reelin on different site(s) than VLDL receptor
that binds two members of the Jun N-terminal kinaseand ApoER2, or it may be a membrane protein that can
(JNK) interacting protein family of scaffold proteins,recruit nonreceptor tyrosine kinases into a complex with
JIP-1 and JIP-2 (Gotthardt et al., 2000; Stockinger et al.,ApoER2, VLDL receptor, and Dab1. The binding in vitro
2000). JIPs organize MAP kinases including JNK into aof Reelin to proteins that are members of a protocadh-
complex (Davis, 2000), suggesting that activation oferin gene family have been reported (Senzaki et al.,
these kinase cascades may play a role in Reelin signal-1999). These so-called cadherin-like neuronal receptors
ing that specifically requires ApoER2.(CNRs) are attractive candidates for the missing Reelin
coreceptors, as they are known to recruit Fyn, one mem-
ber of the Src family of nonreceptor tyrosine kinases, to Regulation of Tau Kinases
Genetic evidence from knockout experiments in micetheir cytoplasmic tails (Kohmura et al., 1998). However,
genetic and biochemical evidence for a role of CNRs in also implicates the serine/threonine kinase Cdk5 and its
activating subunits p35 and p39 (Kwon and Tsai, 2000)Reelin signaling remains to be established.
Other cell surface proteins that have been proposed in Reelin signaling and neuronal migration. Cdk5 forms
a complex with several other cytoplasmic proteins thatas Reelin coreceptors are integrins, in particular a3 (Du-
Neuron
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Figure 2. Hypothetical Model of Roles of Lipoprotein Receptors and Cholesterol in Cellular Signaling
Neurodevelopmental signaling pathways that are potentially affected by cellular cholesterol content or by the interaction of lipoproteins with
receptors involve the Reelin, Wnt, and Shh ligands. Reelin and Wnt receptors are members of the LDL receptor gene family. Ligand binding
may be adversely affected by extracellular lipoproteins that compete for the binding of the signaling ligands to the receptors (VLDL receptor,
ApoER2, LRP5, LRP6) and to cell surface proteoglycans. Cross-talk between Reelin and Wnt pathways is possible. b-catenin is a component
of both signaling pathways, and the serine/threonine kinases Cdk5 and GSK-3b can act on a common substrate, the microtubule stabilizing
protein tau (t). The Sonic hedgehog signal does not involve LDL receptor family members, but it is highly regulated by cholesterol, which
modifies Shh and acts on a sterol-sensing domain in Patched (Ptc). Binding of Shh to Ptc releases the repression of smoothened (Smo),
which signals to Gli and activates transcription. Cholesterol or cholesterol-rich microdomains (caveolae/rafts) of the plasma membrane harbor
some of the components of these signaling pathways and are shown in yellow.
interact with components of the microtubule transport (Hiesberger et al., 1999) and dab1-deficient mice (J.
Cooper, J. H., and M. Mumby, unpublished data), sug-system (Feng et al., 2000; Niethammer et al., 2000; Sa-
saki et al., 2000) (Figure 2). One of these proteins is Lis1 gesting that Cdk5, Reelin, and its receptors are part
of one branch of a signaling pathway that regulates(Lissencephaly 1), the product of another gene that is
defective in a neuronal migration disorder. Furthermore, microtubule dynamics during neuronal migration and
cortical lamination.the microtubule stabilizing protein tau is a major sub-
strate of Cdk5 (Flaherty et al., 2000). In certain neurode- Another major tau kinase is GSK-3b. Intriguingly,
LRP6 has recently been shown to function in the devel-generative diseases, such as frontotemporal dementia
with Parkinsonism (FTDP) and Alzheimer disease, tau opmentally important Wnt signaling pathway in which
GSK-3b plays a key role. LRP6 appears to act as afails to productively associate with microtubules and
instead forms so-called neurofibrillary tangles in the coreceptor for the Wnt family of signaling molecules in
a manner similar to that proposed for the VLDL receptorneuronal cytoplasm (Lee and Trojanowski, 1999). In
these cases, tau is abnormally phosphorylated at certain and ApoER2 in the Reelin signaling pathway (Figure 2).
LRP6 is required for the activation of the Wnt signalingresidues. If Cdk5, as a major tau kinase, were involved
in Reelin signaling, one might expect to see abnormal pathway (Pinson et al., 2000; Tamai et al., 2000; Wehrli
et al., 2000), which involves regulation of the activityphosphorylation of tau in the brains of mice with defects
in this pathway. In fact, abnormal tau phosphorylation of GSK-3b. Modulation of GSK-3b activity affects the
transcription of Wnt target genes (Patapoutian and Rei-has been reported in reeler, vldlr/apoer2 double-mutant
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chardt, 2000; Polakis, 2000), as well as Wnt-mediated Src has been described (Chapman et al., 1999; Webb
et al., 2000). Thrombospondin, another ligand for LRP,axonal remodeling and microtubule reorganization by
phosphorylation of microtubule-associated proteins also binds independently to other receptors that are
present in caveolae or rafts. These large macromolecu-(Lucas et al., 1998). Taken together, these findings sug-
gest that regulation of microtubule structure and trans- lar complexes may thus serve to transiently recruit LDL
receptor family members to cholesterol-rich membraneport processes is a central function of LDL receptor
family members in the developing, and likely also in the domains where the local concentration of cholesterol in
the membrane could profoundly affect such, and at thismature, nervous system.
time still hypothetical, signaling events.
Cholesterol as a Modulator of Cellular
Neurotransmission, LTP, and NMDA receptorsSignaling Events
The LDL receptor gene family, particularly the LRP, alsoA variety of cellular processes including gene transcrip-
has a role in synaptic transmission. Zhuo et al. (2000)tion and signal transduction are regulated by the choles-
found that RAP, a universal inhibitor of ligand bindingterol content of the membrane (Brown and Goldstein,
to LDL receptor family members, blocked almost com-1999; Brown et al., 2000; Simons and Ikonen, 2000) (Fig-
pletely the late-phase long-term potentiation (LTP) inure 2). LDL receptor family members are efficient trans-
hippocampal slices. LRP was implicated because it isporters of cholesterol-containing lipoproteins and may
a receptor for tissue-type plasminogen activator (tPA).participate in the regulation of some of these choles-
tPA induces synaptic potentiation in tPA knockout mice,terol-dependent processes. Examples include the Sonic
which can be completely blocked by RAP. RAP is nothedgehog (Shh) pathway, as well as the activation of
selective for LRP, however, but blocks ligand bindingsome tyrosine kinase and MAP kinase pathways that
to all LDL receptor family members. Thus, other mem-involve cholesterol-rich microdomains on the cell sur-
bers of the family may also mediate the observed effectface such as caveolae (Anderson, 1998) or rafts (Simons
on LTP.and Ikonen, 2000).
A multivalent ligand for LRP, a2-macroglobulin, hasShh is required for the induction of the ventral fore-
been found to induce NMDA receptor–mediated Ca21brain and the spinal cord (Muenke and Beachy, 2000).
influx in cultured primary hippocampal neurons (BacskaiThe autocatalytic cleavage of the Shh precursor requires
et al., 2000). Antibodies against LRP, but not Fab frag-cholesterol, which becomes attached to the newly
ments of the same antibodies, were also effective, sug-formed carboxyl terminus of the protein. Shh binds to
gesting that dimerization of LRP is required. Consistentthe multiple membrane–spanning protein patched (Ptc)
with a postsynaptic role for LRP is the finding that it ison the surface of the target cell releasing the Ptc-medi-
expressed in the postsynaptic density and that LRPated repression on smoothened (Smo), a seven-trans-
and other members of the family bind the postsynapticmembrane protein. Ptc harbors a sterol-sensing domain
density protein PSD95 on their cytoplasmic tails (Gott-similar to those found in HMG-CoA reductase and the
hardt et al., 2000). This multivalent scaffold protein isNiemann-Pick type C1 protein (NPC1). Defects in the
known to interact with NMDA receptors, providing aShh pathway cause holoprosencephaly in man (Roes-
likely physical link between LDL receptor family mem-sler et al., 1996; Muenke and Beachy, 2000) and mice
bers and NMDA receptors in the synapse.(Chiang et al., 1996), where they predominantly affect
the development of the same rostral parts of the neuro-
epithelium that are affected in megalin-deficient mice ApoE Receptors and Alzheimer Disease
The surprising discovery that ApoE4, a relatively com-(Willnow et al., 1996). The phenotype of megalin defi-
ciency is variable and not as severe as that caused by mon isoform of Apolipoprotein E, is a risk factor for late-
onset AD (Schmechel et al., 1993) raised the possibilitycomplete absence of Shh (Chiang et al., 1996). Impaired
cholesterol uptake by megalin and partial compensa- that the receptors to which ApoE binds on the surface
of neurons are also involved in the neurodegenerativetion, either by cellular cholesterol synthesis or by other
receptors, may underlie this milder phenotype. process. All members of the LDL receptor gene family
can bind ApoE and most are abundantly expressed byThe cholesterol content of caveolae (Anderson, 1998)
and rafts (Simons and Ikonen, 2000) also affects signal- neurons in the adult brain. That they may indeed be
involved in the AD process is supported by the emer-ing pathways that involve these structures. Receptor
and nonreceptor, lipid-anchored, protein tyrosine ki- gence of multiple functions of these receptors in neu-
rons (as reviewed above).nases, G proteins, and glycosyl-phosphatidyl-inositol
(GPI)–anchored proteins are associated with these cho- What is special about ApoE4? ApoE4 differs from the
other two major ApoE isoforms in the population, E2lesterol-rich membrane domains. Members of the LDL
receptor family transiently associate with some of these and E3, at two or one amino acid positions, respectively.
At both positions, a Cys ! Arg change is involved thatGPI-linked proteins, specifically with the urokinase re-
ceptor and likely also with some core proteins that har- adds a positive charge to the protein. Thus, ApoE4 car-
ries two and ApoE3 carries one more positive charge(s)bor heparan sulfate side chains. This association with
caveolae or rafts may lead to posttranslational modifica- than ApoE2. The interaction of ApoE with heparansulfate
proteoglycans (HSPGs) on the cell surface and with itstion (e.g., phosphorylation) of proteins attached to the
cytoplasmic tails of LDL receptor family members. In- receptors is mediated by positive charges. ApoE2, in
fact, binds poorly to LDL receptor family members, anddeed, urokinase/inhibitor complexes form a bridge be-
tween LRP and the urokinase receptor, and urokinase sequestration of ApoE on the cell surface greatly en-
hances its ability to interact with its receptors (Mahleyreceptor-dependent activation of MAP kinases and of
Neuron
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Anderson, R.G. (1998). The caveolae membrane system. Annu. Rev.and Rall, 1995). Furthermore, ApoE4 prefers larger lipo-
Biochem. 67, 199–225.protein particles than ApoE2 or ApoE3. For these rea-
Anton, E.S., Kreidberg, J.A., and Rakic, P. (1999). Distinct functionssons, ApoE4 may preferentially interact with the recep-
of alpha3 and alpha(v) integrin receptors in neuronal migration andtors and would be the most effective competitor for
laminar organization of the cerebral cortex. Neuron 22, 277–289.
binding of other ligands that affect neuronal behavior
Bacskai, B.J., Xia, M.Q., Strickland, D.K., Rebeck, G.W., and Hyman,
by interaction with LDL receptor family members. Con- B.T. (2000). The endocytic receptor protein LRP also mediates neu-
sistent with such a model is the finding that ApoE effi- ronal calcium signaling via N-methyl-D-aspartate receptors. Proc.
ciently competes with Reelin for binding to the VLDL Natl. Acad. Sci. USA 97, 11551–11556.
receptor and the ApoER2 (D’Arcangelo et al., 1999). It Baeg, G.H., Lin, X., Khare, N., Baumgartner, S., and Perrimon, N.
(2001). Heparan sulfate proteoglycans are critical for the organiza-is currently not known whether Wnt signaling through
tion of the extracellular distribution of Wingless. Development 128,LRP5 and LRP6 is also affected by ApoE and whether
87–94.this could impair neuronal functions in the adult brain.
Brown, M.S., and Goldstein, J.L. (1986). A receptor-mediated path-However, proteoglycans are also known to participate
way for cholesterol homeostasis. Science 232, 34–47.in Wnt signaling (Baeg et al., 2001). ApoE binding to the
Brown, M.S., and Goldstein, J.L. (1999). A proteolytic pathway thatcell surface may thus conceivably interfere with signal-
controls the cholesterol content of membranes, cells, and blood.
ing by reducing the binding of signaling ligands to pro- Proc. Natl. Acad. Sci. USA 96, 11041–11048.
teoglycans as well as to the receptors. A model, in which
Brown, S.D., Twells, R.C., Hey, P.J., Cox, R.D., Levy, E.R., Soderman,
ApoE exerts an indirect inhibitory rather than a direct A.R., Metzker, M.L., Caskey, C.T., Todd, J.A., and Hess, J.F. (1998).
signaling function, is consistent with the essentially nor- Isolation and characterization of LRP6, a novel member of the low
density lipoprotein receptor gene family. Biochem. Biophys. Res.mal development and brain function in humans and mice
Commun. 248, 879–888.that are genetically deficient in ApoE (Mahley and Rall,
Brown, M.S., Ye, J., Rawson, R.B., and Goldstein, J.L. (2000). Regu-1995).
lated intramembrane proteolysis: a control mechanism conservedReduced microtubule stability is a consequence of
from bacteria to humans. Cell 100, 391–398.tau mutations in FTDP and may contribute to Alzheimer
Chapman, H.A., Wei, Y., Simon, D.I., and Waltz, D.A. (1999). Role ofdisease. Defects in signaling pathways involving ApoE
urokinase receptor and caveolin in regulation of integrin signaling.
receptors—for instance, the Reelin pathway—can also Thromb. Haemost. 82, 291–297.
affect the integrity of microtubules by inducing hyper-
Chen, W.-J., Goldstein, J.L., and Brown, M.S. (1990). NPXY, a se-
phosphorylation of tau (Hiesberger et al., 1999). Both quence often found in cytoplasmic tails, is required for coated pit-
currently known signaling pathways involving LDL re- mediated internalization of the low density lipoprotein receptor. J.
Biol. Chem. 265, 3116–3123.ceptor family members, the Reelin and the Wnt signaling
pathway, apparently act downstream on tau kinases. Chiang, C., Litingtung, Y., Lee, E., Young, K.E., Corden, J.L., West-
phal, H., and Beachy, P.A. (1996). Cyclopia and defective axial pat-Axonal transport is dependent upon microtubules and
terning in mice lacking Sonic hedgehog gene function. Nature 383,interference with these transport processes may explain
407–413.the loss of synapses that is consistently seen in the
D’Arcangelo, G., Miao, G.G., Chen, S.C., Soares, H.D., Morgan, J.I.,brains of patients afflicted with Alzheimer dementia.
and Curran, T. (1995). A protein related to extracellular matrix pro-
teins deleted in the mouse mutant reeler. Nature 374, 719–723.
Conclusions D’Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D.S., Sheldon,
Over the last two years, unexpected functions of the M., and Curran, T. (1999). Reelin is a ligand for lipoprotein receptors.
Neuron 24, 471–479.LDL receptor gene family during the development of the
brain and in neuronal maintenance have been found. Davis, R.J. (2000). Signal transduction by the JNK group of MAP
kinases. Cell 103, 239–252.Receptors that had hitherto been thought to merely
Davis, C.G., van Driel, I.R., Russell, D.W., Brown, M.S., andfunction in mediating cellular import of macromolecules
Goldstein, J.L. (1987). The LDL receptor: Identification of aminohave been integrated into pivotal developmental signal-
acids in cytoplasmic domain required for rapid endocytosis. J. Biol.ing pathways and neurotransmission. The challenge in
Chem. 262, 4075–4082.
the coming years will be to characterize the neuronal
Dong, Y., Lathrop, W., Weaver, D., Qiu, Q., Cini, J., Bertolini, D., andand extraneuronal signaling routes in which this ancient
Chen, D. (1998). Molecular cloning and characterization of LR3, a
and multifunctional gene family is involved and to define novel LDL receptor family protein with mitogenic activity. Biochem.
the biochemical mechanisms by which they influence Biophys. Res. Commun. 251, 784–790.
neuronal cell function and degeneration. Dulabon, L., Olson, E.C., Taglienti, M.G., Eisenhuth, S., McGrath,
B., Walsh, C.A., Kreidberg, J.A., and Anton, E.S. (2000). Reelin binds
Acknowledgments alpha3beta1 integrin and inhibits neuronal migration. Neuron 27,
33–44.
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